Zealand Pharma A/S

ZEAL.CO·Copenhagen·Healthcare

FollowCompareShare

221.70−4.60 (−2.03%)today

As of Oct 19, 12:38 PM CEST · May be delayed up to 15 min · DKK

1D5D1M6MYTD1Y5Y10Y20YAll

MountainLineCandles

Indicators

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close226.30

Open228.00

Day range220.60229.00

52-week range220.60556.00

Off day high−3.19%

Off 52-week high−60.13%

Volume94.17K

Avg. volume (3M)375.35K

Market cap14.71B

EPS (TTM)38.64

Forward P/E29.74

P/E ratio (TTM)5.74

Dividend yield—

Beta (5Y)0.61

Shares outstanding66.33M

Short interest—

Earnings dateNov 12, 2026

Analyst target398.50

Profit margin59.02%

Related companies

Compare ›

Moves togetherAlso watched

The stocks whose daily moves over the past year went most closely with ZEAL's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
BAVABavarian Nordic A/SBAVA.CO · Correlation 0.39	17.74B	236.40	−0.25%

What visitors to ZEAL's page also look at.

Company	Mkt cap	Price	Today
GMABGenmab A/SGMAB.CO	153.97B	2,504.00	+0.08%
BAVABavarian Nordic A/SBAVA.CO	17.74B	236.40	−0.25%
AMBUAmbu A/SAMBU-B.CO	20.11B	77.15	−1.53%
NKTCNKT A/SNKT.CO	—	831.00	−2.18%
GNCOGN Store Nord A/SGN.CO	15.36B	105.50	−0.75%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All ZEAL.CO news ›

MarketScreener·2d agoPositive

Royalty Pharma plc and Zealand Pharma A/S Enter into Rusfertide Funding Agreement for $100 Million

Royalty Pharma plc announced an agreement for $100 million in funding to Zealand Pharma A/S in exchange for Zealand Pharma A/S?s economics related to rusfertide , a potential first-in-class therapy... Royalty Pharma plc announced an…

MassBio·5d ago

Member Spotlight: Zealand Pharma A/S

Massachusetts Biotechnology Council Zealand Pharma is a biotechnology company transforming metabolic health so millions of people can live without limits. With the opening of its new research hub at 35 CambridgePark Drive, Zealand Pharma…

Markets Daily·5d agoPositive

Analyzing Zealand Pharma A/S (OTCMKTS:ZLDPF) & Fractyl Health (NASDAQ:GUTS)

Posted by Michael Walen on Oct 14th, 2026 Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Free Report) and Fractyl Health (NASDAQ:GUTS – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two…

MarketScreener·5d agoPositive

Zealand Pharma A/S and Generate Biomedicines Inc. Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with Ai for Metabolic Diseases

Zealand Pharma A/S announced a multi-target strategic collaboration with Generate Biomedicines Inc. . Under the collaboration, the companies intend to design and develop multispecific protein... Zealand Pharma A/S announced a multi-target…

MarketScreener·Oct 9

Zealand Pharma A/S : Insider Transactions

Follow insider transactions on Zealand Pharma A/S in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Zealand Pharma A/S Biotechnology & Medical Research Latest insider…

MarketScreener·Oct 9Negative

All Transcripts on Zealand Pharma A/S (ZEAL)

Find all the latest transcripts on Zealand Pharma A/S Transcripts Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much weight October 01, 2026 at 07:54 am EDT All financial news and data…

MarketScreener·Oct 9Negative

Zealand Pharma A/S: Official Announcements - Stock Market News

Find the latest press releases and official documents published by Zealand Pharma A/S on MarketScreener. Press Releases Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much weight October 01,…

MarketScreener·Oct 9

Zealand Pharma A/S Stock (ZEAL) - Quote Nasdaq Copenhagen

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2025, the Group had a portfolio of 8 products in clinical development…

MarketScreener·Oct 9

Zealand Pharma A/S: Relative Strength Chart - Stock Nasdaq Copenhagen

Compare Zealand Pharma A/S with the company of your choice via a Relative Strength chart. Real-time ZEAL price, Nasdaq Copenhagen stock exchange Relative Strength Chart Zealand Pharma A/S Biotechnology & Medical Research All financial news…

MarketScreener·Oct 9Negative

Zealand Pharma A/S: News in other languages | ZEAL | DK0060257814

Zealand Pharma A/S: News, information and stories for Zealand Pharma A/S | Nasdaq Copenhagen: ZEAL | Nasdaq Copenhagen Other languages Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much…

From articles in the 4Search news index.

In the news

11mentions in 30 days

11with it in the headline

Mixedsentiment

Mentioned with

Novo Nordisk11Zealand Pharma10Eli Lilly and Company9Pfizer9Johnson & Johnson8Merck & Co., Inc.8Mrk) Merck & Co., Inc.8Novartis8

People in the coverage

Adam Steensberg8Basaglar8Jardiance8Neshat Anis Ahmadi8Sarita Garza8Fennell7

Themes

Lly8Pharma8Zealand7Jnj6Mrk6Buy-Back4Share4Denmark3

Most coverage from

1. marketscreener.com9
2. massbio.org1
3. themarketsdaily.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.